Lukáš Sobíšek

620 total citations
30 papers, 346 citations indexed

About

Lukáš Sobíšek is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Lukáš Sobíšek has authored 30 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 12 papers in Neurology and 9 papers in Rheumatology. Recurrent topics in Lukáš Sobíšek's work include Multiple Sclerosis Research Studies (20 papers), Peripheral Neuropathies and Disorders (8 papers) and Systemic Lupus Erythematosus Research (7 papers). Lukáš Sobíšek is often cited by papers focused on Multiple Sclerosis Research Studies (20 papers), Peripheral Neuropathies and Disorders (8 papers) and Systemic Lupus Erythematosus Research (7 papers). Lukáš Sobíšek collaborates with scholars based in Czechia, United States and Italy. Lukáš Sobíšek's co-authors include Dana Horáková, Eva Havrdová, Jan Krásenský, Manuela Vaněčková, Zdeněk Seidl, Tomáš Uher, Robert Zivadinov, Michaela Týblová, Niels Bergsland and Tomáš Kalinčík and has published in prestigious journals such as Neurology, Scientific Reports and Journal of Lipid Research.

In The Last Decade

Lukáš Sobíšek

25 papers receiving 342 citations

Peers

Lukáš Sobíšek
Laura Willis United States
Joshua Barton Australia
Mathew Pulicken United States
Jennifer C. Fulton United States
Zsuzsanna Liptak United States
Mor Lavie Israel
Lukáš Sobíšek
Citations per year, relative to Lukáš Sobíšek Lukáš Sobíšek (= 1×) peers Kjell-Morten Myhr

Countries citing papers authored by Lukáš Sobíšek

Since Specialization
Citations

This map shows the geographic impact of Lukáš Sobíšek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukáš Sobíšek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukáš Sobíšek more than expected).

Fields of papers citing papers by Lukáš Sobíšek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukáš Sobíšek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukáš Sobíšek. The network helps show where Lukáš Sobíšek may publish in the future.

Co-authorship network of co-authors of Lukáš Sobíšek

This figure shows the co-authorship network connecting the top 25 collaborators of Lukáš Sobíšek. A scholar is included among the top collaborators of Lukáš Sobíšek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukáš Sobíšek. Lukáš Sobíšek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fox, Karin A., Lukáš Sobíšek, Mina Mhallem Gzirí, et al.. (2024). Emergency delivery in case of suspected placenta accreta spectrum: Can it be predicted?. Acta Obstetricia Et Gynecologica Scandinavica. 104(S1). 29–37. 1 indexed citations
3.
Sobíšek, Lukáš, Ivana Štětkářová, Pavel Štourač, et al.. (2021). Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS. Frontiers in Neurology. 11. 593527–593527. 3 indexed citations
4.
Srpová, Barbora, Lukáš Sobíšek, Klára Novotná, et al.. (2021). The clinical and paraclinical correlates of employment status in multiple sclerosis. Neurological Sciences. 43(3). 1911–1920. 6 indexed citations
5.
Novotný, Michal, Jan Krejsek, Lukáš Sobíšek, et al.. (2021). Multiple sclerosis and immune system biomarkers: Novel comparison in glatiramer acetate and interferon beta-1a-treated patient groups. Multiple Sclerosis and Related Disorders. 53. 103082–103082. 1 indexed citations
6.
Krejsek, Jan, Lukáš Sobíšek, Blanka Klímová, et al.. (2020). The role of the immune system and the biomarker CD3 + CD4 + CD45RA−CD62L− in the pathophysiology of migraine. Scientific Reports. 10(1). 12277–12277. 13 indexed citations
7.
Uher, Tomáš, Niels Bergsland, Jan Krásenský, et al.. (2020). Interpretation of Brain Volume Increase in Multiple Sclerosis. Journal of Neuroimaging. 31(2). 401–407. 5 indexed citations
8.
Angelucci, Francesco, Jan Krejsek, Lukáš Sobíšek, et al.. (2020). Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase. Journal of Clinical Medicine. 9(5). 1468–1468. 7 indexed citations
9.
Andělová, Michaela, Tomáš Uher, Jan Krásenský, et al.. (2019). Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis. Frontiers in Neurology. 10. 820–820. 14 indexed citations
10.
Ernest, Jan, et al.. (2019). One-Year Results of Fixed Aflibercept Treatment Regime in Type 3 Neovascularization. Ophthalmologica. 243(1). 58–65. 4 indexed citations
11.
Preiningerová, Jana Lízrová, et al.. (2018). Do eyes with and without optic neuritis in multiple sclerosis age equally?. Neuropsychiatric Disease and Treatment. Volume 14. 2281–2285. 5 indexed citations
12.
Vyšata, Oldřich, Lukáš Sobíšek, Blanka Klímová, et al.. (2018). Lymphocyte populations and their change during five-year glatiramer acetate treatment. Neurologia i Neurochirurgia Polska. 52(5). 587–592.
13.
Vaněčková, Manuela, Lukáš Sobíšek, Michaela Andělová, et al.. (2018). Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year employment status in multiple sclerosis patients. Journal of the Neurological Sciences. 388. 87–93. 5 indexed citations
14.
Burgetová, Andrea, Petr Dušek, Manuela Vaněčková, et al.. (2017). Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis. American Journal of Neuroradiology. 38(6). 1079–1086. 33 indexed citations
15.
Uher, Tomáš, Jan Krásenský, Lukáš Sobíšek, et al.. (2017). Cognitive clinico‐radiological paradox in early stages of multiple sclerosis. Annals of Clinical and Translational Neurology. 5(1). 81–91. 22 indexed citations
16.
Novotná, Klára, Jana Lízrová Preiningerová, Lukáš Sobíšek, & Eva Havrdová. (2017). What Variability of Treatment Effect of Fampridine Can We Expect in People with Multiple Sclerosis?. 4(3). 1 indexed citations
17.
Uher, Tomáš, Jan Krásenský, Manuela Vaněčková, et al.. (2017). A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long‐Term Comparative Study. Journal of Neuroimaging. 27(6). 620–629. 21 indexed citations
18.
Novotná, Klára, Lukáš Sobíšek, Dana Horáková, Eva Havrdová, & Jana Lízrová Preiningerová. (2016). Quantification of Gait Abnormalities in Healthy-Looking Multiple Sclerosis Patients (with Expanded Disability Status Scale 0-1.5). European Neurology. 76(3-4). 99–104. 15 indexed citations
19.
Uher, Tomáš, Eva Havrdová, Lukáš Sobíšek, et al.. (2016). Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?. Multiple Sclerosis Journal. 23(2). 242–252. 34 indexed citations
20.
Uher, Tomáš, Manuela Vaněčková, Maria Pia Sormani, et al.. (2016). Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach. European Journal of Neurology. 24(2). 292–301. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026